Alternative Cancer Treatment, Immunotherapy

Immunotherapy Succeeded when Standard Treatments Failed; Cancer Patient Calls Issels Results ‘Amazing’

Immunotherapy Success for Nicole Tupper
Immunotherapy Success for Nicole Tupper

“Come. Especially if you’re still in the early stages [and] you want to know what to do when you first get diagnosed. Try this out first, you know. It’s an amazing option. If you’re willing to do the work and just listen to what they have to say, I think anyone will see results.” — Nicole Tupper, Issels Integrated Immunotherapy patient.

That’s the advice Nicole Tupper of Los Angeles offers other cancer patients after her successful experience at the Issels Integrative Medical Center in Santa Barbara, California. The young actress came to Issels after chemotherapy and radiation failed to successfully address the return of adenocarcinoma of the appendix. As Nicole notes in her video testimony, within 5 months of beginning her Issels treatment Nicole saw a 12 cm tumor “basically disappear” and she has realized a greater than 50% reduction in the number of tumors in her abdomen.

“It would be so nice if I had come here first,” Nicole said, “and that way I would be making the progress I am making but without having to get over the side effects of other things that I had done that were more detrimental to my system.” (Click here to listen to Issels Treatment Reviews in patients’ own words.)

After extensive surgery to remove a grapefruit size mass on her left ovary, Nicole was diagnosed with stage IV of a rare form of appendix cancer in  2009 and received chemotherapy. When the cancer returned in February 2012, she tried radiation. Nicole came to Issels with her abdomen full of tumors “as a last resort,” but it has proven to be a life-saving decision.

Watch her video story at YouTube.com or by clicking the video below.

Alternative Cancer Treatment

What Women Need to Know about BRCA and Breast Cancer

October is Breast Cancer Awareness Month
October is Breast Cancer Awareness Month

With all the news stories appearing in support of National Breast Cancer Awareness Month, BRCA is a hot topic. As we noted last time, the highly publicized decision of some celebrities who carry the BRCA gene mutation, including actress Angelia Jolie, to undergo preventive double mastectomies has influenced more women to seek the same treatment. But cancer treatment experts say that publicity surrounding celebrity cancer prevention and treatment choices has generated an outsized fear of BRCA that is leading some women to take more dire action than may be necessary.

Naturally, each woman’s medical history and prognosis are different; but according to the Mayo Clinic, the BRCA genetic mutation is a causal factor in only about 5% of breast cancers and 10% to 15% of ovarian cancers. Even if you do carry the BRCA gene mutation, a double mastectomy may not be necessary. If you are a breast cancer survivor who does not carry the BRCA gene, your risk of developing cancer in the other breast is typically so low that a double mastectomy may not be medically indicated.

There is concern in the cancer community that fear of BRCA is leading women to make treatment choices without fully exploring all their options. Cancer is a very individualistic disease and each person’s response to cancer and cancer treatment is unique. Your decisions about preventive measures and treatment choices should be made in consultation with your Issels cancer treatment team and designed to address your personal health needs; not based on the treatment that worked for your friend, a family member or a celebrity.

Alternative Cancer Treatment, Cancer Survivors

Celebrity Cancer Choices Shouldn’t Influence Your Treatment Decision

Celebrity Sunglasses
Celebrity Cancer Choices Shouldn’t Influence Your Treatment Decision

The stars are coming out for cancer this month in support of National Breast Cancer Awareness Month. Television stars are appearing in public service announcements to promote cancer awareness. Celebrities from movies, TV and music are appearing on talk shows and granting interviews to share their personal stories about cancer. But celebrity cancer support can be a two-edged sword.

When celebrities such as Angelina Jolie, Sharon Osbourne and Wanda Sykes share their personal cancer stories, people listen — and they start talking about cancer. “When a celebrity comes out about their experience with breast cancer, it really invigorates the conversation,” Nancy Healey, executive director of the Central and South Jersey Affiliate of Susan G. Komen for the Cure, told the Asbury Park Press.

The downside is that the public often places undo importance on celebrity statements which can lead people to base their own cancer treatments on celebrity experiences. After Angelina Jolie discovered she carries the BRCA gene linked to increased breast cancer risk and went public with her decision to have a preventive double mastectomy, cancer treatment centers noticed an increase in mastectomy requests.

But, as Healey points out, “Breast cancer is different for everyone. It is really a question of finding out what works for you.” In other words, just because a certain cancer treatment worked for your favorite movie star or your best friend or your sister, doesn’t mean it’s the right choice for you.

A leader in individualized immunotherapy, Issels Integrative Oncology creates personalized cancer treatment programs that are as unique as each patient’s response to cancer.

Cancer Care Tips

U.S. Goes Pink to Promote Breast Cancer Awareness

The Pink Breast Cancer Awareness Ribbon
The Pink Breast Cancer Awareness Ribbon

From pink yogurt lids to blushing tow trucks to pink shoes on the NFL gridiron,  pink has become October’s most fashionable color in recognition of National Breast Cancer Awareness Month. More than 2.8 million American women are undergoing or have completed breast cancer treatment.

One in eight U.S. women will develop invasive breast cancer. According to BreastCancer.org, nearly 300,000 women are expected to be diagnosed with breast cancer this year: 232,340 with invasive breast cancer and 64,640 with non-invasive breast cancer. For nearly 40,000 women that diagnosis will prove fatal.

Men are also at risk of developing breast cancer, but their risk is far lower than it is for women. BreastCancer.org estimates a man’s lifetime risk of breast cancer at 1 in 1,000. An estimated 2,240 men are expected to be diagnosed with invasive breast cancer this year.

After skin cancer, breast cancer is the most commonly diagnosed form of cancer in women, accounting for nearly 30% of all female cancers. Breast cancer is also one of the top two cancer killers among women. Only lung cancer is more fatal.

Despite those grim figures, breast cancer rates have been slowly decreasing since 2000. Greater public awareness, better cancer screening methods, reduced use of hormone replacement therapy and advanced cancer treatment options appear to be contributing factors in reducing both the risk and fatality of breast cancer.

Despite heavy publicity about the increased risk of breast cancer among women who carry BRCA gene mutations or have a family history of breast cancer, “about 85% of breast cancers occur in women who have no family history of breast cancer,” notes BreastCancer.org.

Alternative Cancer Treatment, Immunotherapy

Personalized Cancer Therapies are the Future

Immunotherapy
Immunotherapy

Surgery, chemotherapy and radiation – for decades, these three treatments have represented the standard in cancer management, despite the risky side effects of each one.

Today, however, an alternative method to treat cancer is gaining attention from researchers, doctors and allied professionals. Cancer immunotherapies, including vaccines, is a therapy model based on a non-toxic approach that uses antibodies to stimulate the body’s own immune system to fight off malignant cells before they can form into dangerous tumors, reducing the rate of recurrence and increasing remission.

“The primary advantages of active immunotherapy are its relative lack of side effects, its specificity against target tumor cells and the generation a long-lasting memory response against tumor-specific antigens,” notes the National Institutes of Health.

Such personalized approaches have already made headlines in their survival-rate effectiveness in the treatment of some ovarian and prostate cancers.

Bringing personalized immunotherapy into the mainstream as an alternative or complementary cancer treatment has been the mission of many treatment centers. In recognition of the advancements made in this form of therapy, June has been declared “Cancer Immunotherapy Awareness Month” by the nonprofit Cancer Research Institute. “For 60 years, CRI has remained steadfast in its dedication to realizing immunotherapy’s potential to treat and cure cancer,” said Jill O’Donnell-Tormey, Ph.D., chief executive officer and director of scientific affairs at the Cancer Research Institute. “Because of this work, today safe and powerful new immune-based treatment options are finally available, and we are dedicated to increasing awareness and support to bring them to more patients sooner.”

Issels Integrative Cancer Treatment Centers specialize in targeted immunotherapy of cancer. We invite you to visit our website to find out more about how these cutting edge new therapies may be able to help you.

After Cancer, Cancer Survivors

Scientists Find Similar Patterns in Multiple Types of Cancer Tumors

DNA
Genome Mapping

Scientists mapping cancer genomes have found surprising similarities between cancer tumors that originate in different organs. Their findings could one day lead to genetically engineered cancer treatments capable of targeting specific cancer genes. Advanced targeted cell therapy now allows cancer treatment specialists to target specific types of tissue at the cellular level; but this research breakthrough could lead to treatments that can turn on or off specific genes that initiate cancer and govern the growth of cancer cells. The discovery was made by biomolecular engineers working on the National Institutes of Health sponsored Cancer Genome Atlas which seeks to catalog the DNA of the thousands of tumor types included in the many varieties of cancer.

Shifting the focus of cancer research and treatment from the cellular to the genetic level could also lead to new treatments for cancers that have so far failed to respond to treatment, study co-author Josh Stuart of the University of California-Santa Cruz told the Los Angeles Times. Typically, the cancer drugs currently used in traditional medicine are designed to treat cancers of a specific organ or tissue type, such as breast cancer or lung cancer. Based on this new research, scientists hope to develop cross-cancer treatments that can cross organ and tissue boundaries to attack tumors with genetic similarities no matter where in the body they are located. In the future, cancer may be identified and treated by tumor type rather than body location.

The Cancer Genome Atlas project is expanding our knowledge of how cancerous tumors form and grow; but perhaps more importantly, it is allowing scientist to see connections between different types of cancer that could eventually lead to a cure for cancer.

Individualized Cancer Treatment